• OPEN AN ACCOUNT
Indian Indices
Sensex
81,028.02 1,718.01
( 2.17%)
Global Indices
Nasdaq
51,462.04 -82.02
(-0.16%)
Dow Jones
7,424.83 50.10
(0.68%)
Hang Seng
57,293.47 -3,784.43
(-6.20%)
Nikkei 225
10,662.59 -120.07
(-1.11%)
Forex
USD-INR
94.41 -0.18
(-0.19%)
EUR-INR
106.07 -0.23
(-0.22%)
GBP-INR
127.18 -0.23
(-0.18%)
JPY-INR
0.60 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
97.3802066
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
127.84
446276.3
EPS(TTM)
Face Value()
Div & Yield %
14.55
1
0.86
 

vjil consulting ltd
Royal India Corporation consolidated net profit rises 330.64% in the March 2026 quarter
Jun 01,2026
Net profit of Royal India Corporation rose 330.64% to Rs 46.94 crore in the quarter ended March 2026 as against Rs 10.90 crore during the previous quarter ended March 2025. Sales declined 99.29% to Rs 0.50 crore in the quarter ended March 2026 as against Rs 70.22 crore during the previous quarter ended March 2025.

For the full year,net profit rose 383.38% to Rs 52.35 crore in the year ended March 2026 as against Rs 10.83 crore during the previous year ended March 2025. Sales declined 78.84% to Rs 46.55 crore in the year ended March 2026 as against Rs 220.02 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales0.5070.22 -99 46.55220.02 -79
OPM %-626.008.17 -1.465.78 -
PBDT71.2011.56 516 76.6711.50 567
PBT71.1111.56 515 76.5311.48 567
NP46.9410.90 331 52.3510.83 383